PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28464271-0	2017	Picroside II Inhibits RANKL-Mediated Osteoclastogenesis by Attenuating the NF-kappaB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice.	picroside II	0-12	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	22-27	
28464271-6	2017	Results demonstrated picroside II strongly inhibited RANKL-induced osteoclast formation when added during the early stage of BMMs cultures, suggesting that it acts on osteoclast precursors to inhibit RANKL/RANK signaling.	picroside II	21-33	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	53-58	
28464271-6	2017	Results demonstrated picroside II strongly inhibited RANKL-induced osteoclast formation when added during the early stage of BMMs cultures, suggesting that it acts on osteoclast precursors to inhibit RANKL/RANK signaling.	picroside II	21-33	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	200-205